Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group Ltd.; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals, Inc.; eFFECTOR Therapeutics, Inc.; Dynatronics Corporation; and Canna-Global Acquisition Corp. from The Nasdaq Stock Market-To The Moon - Tiger Brokers Online Investing Community

Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group Ltd.; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals, Inc.; eFFECTOR Therapeutics, Inc.; Dynatronics Corporation; and Canna-Global Acquisition Corp. from The Nasdaq Stock Market

GlobeNewswire07-17

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of CONX Corp. CONX Corp.’s securities were suspended on May 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Priveterra Acquisition Corp. II. Priveterra Acquisition Corp. II’s securities were suspended on May 10, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Yield10 Bioscience, Inc. Yield10 Bioscience, Inc.’s securities were suspended on May 16, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of Aesthetic Medical International Holdings Group Ltd. Aesthetic Medical International Holdings Group Ltd.’s securities were suspended on May 21, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, and warrants of Breeze Holdings Acquisition Corp. Breeze Holdings Acquisition Corp.’s securities were suspended on May 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, units, and warrants of Quadro Acquisition One Corp. Quadro Acquisition One Corp.’s securities were suspended on May 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DermTech, Inc. DermTech, Inc.’s securities were suspended on June 27, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of TRACON Pharmaceuticals, Inc. TRACON Pharmaceuticals, Inc.’s securities were suspended on June 28, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common and warrants of eFFECTOR Therapeutics, Inc. eFFECTOR Therapeutics, Inc.’s securities were suspended on July 3, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Dynatronics Corporation. Dynatronics Corporation’s securities were suspended on July 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, warrants, and units of Canna-Global Acquisition Corp. Canna-Global Acquisition Corp.’s securities were suspended on July 9, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments